Venous thromboembolism

BMJ. 2006 Jan 28;332(7535):215-9. doi: 10.1136/bmj.332.7535.215.
No abstract available

Publication types

  • Review

MeSH terms

  • Anticoagulants / therapeutic use
  • Fondaparinux
  • Forecasting
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Polysaccharides / therapeutic use
  • Pulmonary Embolism / etiology
  • Pulmonary Embolism / prevention & control
  • Pulmonary Embolism / therapy
  • Risk Factors
  • Thromboembolism* / etiology
  • Thromboembolism* / prevention & control
  • Thromboembolism* / therapy
  • Thrombolytic Therapy / methods
  • Venous Thrombosis* / etiology
  • Venous Thrombosis* / prevention & control
  • Venous Thrombosis* / therapy
  • Vitamin K / antagonists & inhibitors

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Polysaccharides
  • Vitamin K
  • Fondaparinux